3-142459302-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001184.4(ATR):​c.7274G>A​(p.Arg2425Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.147 in 1,613,772 control chromosomes in the GnomAD database, including 18,203 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2425L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.13 ( 1344 hom., cov: 32)
Exomes 𝑓: 0.15 ( 16859 hom. )

Consequence

ATR
NM_001184.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.0370

Publications

70 publications found
Variant links:
Genes affected
ATR (HGNC:882): (ATR serine/threonine kinase) The protein encoded by this gene is a serine/threonine kinase and DNA damage sensor, activating cell cycle checkpoint signaling upon DNA stress. The encoded protein can phosphorylate and activate several proteins involved in the inhibition of DNA replication and mitosis, and can promote DNA repair, recombination, and apoptosis. This protein is also important for fragile site stability and centrosome duplication. Defects in this gene are a cause of Seckel syndrome 1. [provided by RefSeq, Aug 2017]
ATR Gene-Disease associations (from GenCC):
  • Seckel syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Illumina, G2P, Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome
    Inheritance: Unknown, AD Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • Seckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • familial prostate carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.001532197).
BP6
Variant 3-142459302-C-T is Benign according to our data. Variant chr3-142459302-C-T is described in ClinVar as Benign. ClinVar VariationId is 136470.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.158 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATRNM_001184.4 linkc.7274G>A p.Arg2425Gln missense_variant Exon 43 of 47 ENST00000350721.9 NP_001175.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATRENST00000350721.9 linkc.7274G>A p.Arg2425Gln missense_variant Exon 43 of 47 1 NM_001184.4 ENSP00000343741.4

Frequencies

GnomAD3 genomes
AF:
0.127
AC:
19374
AN:
152002
Hom.:
1340
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0810
Gnomad AMI
AF:
0.126
Gnomad AMR
AF:
0.110
Gnomad ASJ
AF:
0.0845
Gnomad EAS
AF:
0.101
Gnomad SAS
AF:
0.0982
Gnomad FIN
AF:
0.163
Gnomad MID
AF:
0.111
Gnomad NFE
AF:
0.160
Gnomad OTH
AF:
0.135
GnomAD2 exomes
AF:
0.131
AC:
32811
AN:
251230
AF XY:
0.131
show subpopulations
Gnomad AFR exome
AF:
0.0795
Gnomad AMR exome
AF:
0.0994
Gnomad ASJ exome
AF:
0.0798
Gnomad EAS exome
AF:
0.0982
Gnomad FIN exome
AF:
0.166
Gnomad NFE exome
AF:
0.160
Gnomad OTH exome
AF:
0.129
GnomAD4 exome
AF:
0.149
AC:
217372
AN:
1461652
Hom.:
16859
Cov.:
34
AF XY:
0.147
AC XY:
106950
AN XY:
727134
show subpopulations
African (AFR)
AF:
0.0736
AC:
2465
AN:
33474
American (AMR)
AF:
0.101
AC:
4513
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0794
AC:
2074
AN:
26126
East Asian (EAS)
AF:
0.114
AC:
4541
AN:
39678
South Asian (SAS)
AF:
0.100
AC:
8636
AN:
86246
European-Finnish (FIN)
AF:
0.167
AC:
8918
AN:
53412
Middle Eastern (MID)
AF:
0.105
AC:
608
AN:
5768
European-Non Finnish (NFE)
AF:
0.159
AC:
177307
AN:
1111846
Other (OTH)
AF:
0.138
AC:
8310
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
11116
22232
33348
44464
55580
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6100
12200
18300
24400
30500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.127
AC:
19375
AN:
152120
Hom.:
1344
Cov.:
32
AF XY:
0.125
AC XY:
9319
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.0808
AC:
3356
AN:
41532
American (AMR)
AF:
0.110
AC:
1675
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.0845
AC:
293
AN:
3468
East Asian (EAS)
AF:
0.101
AC:
522
AN:
5160
South Asian (SAS)
AF:
0.0989
AC:
477
AN:
4824
European-Finnish (FIN)
AF:
0.163
AC:
1727
AN:
10580
Middle Eastern (MID)
AF:
0.112
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
0.160
AC:
10888
AN:
67962
Other (OTH)
AF:
0.137
AC:
289
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
859
1718
2576
3435
4294
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
220
440
660
880
1100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.144
Hom.:
6024
Bravo
AF:
0.120
TwinsUK
AF:
0.161
AC:
597
ALSPAC
AF:
0.147
AC:
568
ESP6500AA
AF:
0.0881
AC:
388
ESP6500EA
AF:
0.158
AC:
1357
ExAC
AF:
0.133
AC:
16083
Asia WGS
AF:
0.0990
AC:
347
AN:
3478
EpiCase
AF:
0.155
EpiControl
AF:
0.150

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 18, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:3
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 27, 2016
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: The c.7274G>A variant involves the alteration of a non-conserved nucleotide and 4/4 in silico tools predict a neutral outcome. The variant was observed in the large, broad control population, ExAC, with an allele frequency of 13.3% which includes 1212 homozygous occurrences, strong evidence this variant is a benign polymorphism. The variant has been reported as benign by multiple reputable clinical labs/publications. Taken together, this variant has been classified as Benign. -

Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome Benign:2
Feb 08, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Seckel syndrome 1 Benign:2
Feb 08, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
0.68
DANN
Benign
0.84
DEOGEN2
Benign
0.053
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.23
N
LIST_S2
Benign
0.71
T
MetaRNN
Benign
0.0015
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.61
N
PhyloP100
0.037
PrimateAI
Benign
0.24
T
PROVEAN
Benign
0.040
N
REVEL
Benign
0.17
Sift
Benign
0.56
T
Sift4G
Benign
0.44
T
Polyphen
0.0
B
Vest4
0.022
MPC
0.72
ClinPred
0.0046
T
GERP RS
-9.1
Varity_R
0.046
gMVP
0.072
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229032; hg19: chr3-142178144; COSMIC: COSV63383988; COSMIC: COSV63383988; API